InvestorsHub Logo
Followers 58
Posts 10362
Boards Moderated 1
Alias Born 09/21/2016

Re: falconer66a post# 277362

Tuesday, 10/20/2020 10:25:53 AM

Tuesday, October 20, 2020 10:25:53 AM

Post# of 471589
falconer66a Brilliant assessment.

Miyamoto Musashi would be very proud of such a strategy. He (Dr.M.) has his opponents surrounded, and they do not yet know what is about to happen. Brilliant strategy.

Once and for all, this clever maneuver will validate and confirm the blarcamesine mechanism(s) of action, facilitating favorable activation of the sigma-1 receptor protein. The Alzheimer's people are going to see the quite favorable Parkinson's results, and then have to explain to various Alzheimer's stakeholders why they haven't taken this approach to Alzheimer's. "Wow, look at what that drug did for people with Parkinson's. And Anavex is testing it on people with Alzheimer's. No doubt, blarcamesine is now in the Alzheimer's game."



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News